Evidence map›Paper›PMID 28940194›Full record

ArticleThe Journal of pathology2017

A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.

Christiane Daniela Fichter, Camilla Maria Przypadlo, Achim Buck, Nicola Herbener, Bianca Riedel, Luisa Schäfer, Hiroshi Nakagawa, Axel Walch, Thomas Reinheckel, Martin Werner and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Christiane Daniela FichterInstitute for Surgical Pathology, Medical Centre, University of Freiburg, Freiburg, Germany.
Camilla Maria PrzypadloInstitute for Surgical Pathology, Medical Centre, University of Freiburg, Freiburg, Germany.
Achim BuckResearch Unit Analytical Pathology, Helmholtz Zentrum München, Neuherberg, Germany.
Nicola HerbenerInstitute for Surgical Pathology, Medical Centre, University of Freiburg, Freiburg, Germany.
Bianca RiedelInstitute for Surgical Pathology, Medical Centre, University of Freiburg, Freiburg, Germany.
Luisa SchäferInstitute for Surgical Pathology, Medical Centre, University of Freiburg, Freiburg, Germany.
Hiroshi NakagawaDivision of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Axel WalchResearch Unit Analytical Pathology, Helmholtz Zentrum München, Neuherberg, Germany.
Thomas ReinheckelFaculty of Medicine, University of Freiburg, Freiburg, Germany.
Martin WernerInstitute for Surgical Pathology, Medical Centre, University of Freiburg, Freiburg, Germany.
Silke LassmannInstitute for Surgical Pathology, Medical Centre, University of Freiburg, Freiburg, Germany.
University Medical Center Freiburg · DEHeidelberg University · DEHelmholtz Zentrum München · DEUniversity of Freiburg · DEGerman Cancer Research Center · DEHospital of the University of Pennsylvania · US

Funding

TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 1997 to 2026
$32.5M
Transformed Esophageal Epithelial Cells and the Tumor MicroenvironmentP01CA098101 · NCI · UNIVERSITY OF PENNSYLVANIA · PI NAKAGAWA, HIROSHI · 2003 to 2023
$31.7M
NCI NIH HHS P01 CA098101NIDDK NIH HHS P30 DK050306
6 · The paper itself

Abstract

Oesophageal squamous cell carcinomas and oesophageal adenocarcinomas show distinct patterns of ErbB expression and dimers. The functional effects of specific ErbB homodimers or heterodimers on oesophageal (cancer) cell behaviour, particularly invasion during early carcinogenesis, remain unknown. Here, a new cellular model system for controlled activation of epidermal growth factor receptor (EGFR) or human epidermal growth factor receptor 2 (HER2) and EGFR-HER2 or HER2-human epidermal growth factor receptor 3 (HER3) homodimers and heterodimers was studied in non-neoplastic squamous oesophageal epithelial Het-1A cells. EGFR, HER2 and HER3 intracellular domains (ICDs) were fused to dimerization domains (DmrA/DmrA and DmrC), and transduced into Het-1A cells lacking ErbB expression. Dimerization of EGFR, HER2 or EGFR-HER2 and HER2-HER3 ICDs was induced by synthetic ligands (A/A or A/C dimerizers). This was accompanied by phosphorylation of the respective EGFR, HER2 and HER3 ICDs and activation of distinct downstream signalling pathways, such as phospholipase Cγ1, Akt, STAT and Src family kinases. Phenotypically, ErbB dimers caused cell rounding and non-apoptotic blebbing, specifically in EGFR-HER2 and HER2-HER3 heterodimer cells. In a Transwell assay, cell migration velocity was elevated in HER2 dimer cells as compared with empty vector cells. In addition, HER2 dimer cells showed in increased cell invasion, reaching significance for induced HER2-HER3 heterodimers (P = 0.015). Importantly, in three-dimensional organotypic cultures, empty vector cells grew as a superficial cell layer, resembling oesophageal squamous epithelium. In contrast, induced HER2 homodimer cells were highly invasive into the matrix and formed cell clusters. This was associated with partial loss of cytokeratin 7 (when HER2 homodimers were modelled) and p63 (when EGFR-HER2 heterodimers were modelled), which suggests a change or loss of squamous cell differentiation. Controlled activation of specific EGFR, HER2 and HER3 homodimers and heterodimers caused oesophageal squamous epithelial cell migration and/or invasion, especially in a three-dimensional microenvironment, thereby functionally identifying ErbB homodimers and heterodimers as important drivers of oesophageal carcinogenesis. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Indexed as

Cell MovementCarcinoma, Squamous CellCell DifferentiationCell Line, TumorEpithelial CellsErb-b2 Receptor Tyrosine KinasesErbB ReceptorsEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaHumansIntracellular Signaling Peptides and ProteinsMetabolomicsNeoplasm InvasivenessPhosphorylationProtein BindingProtein Interaction Domains and MotifsEGFR protein, humanERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesERBB3 protein, humanErbB ReceptorsIntracellular Signaling Peptides and ProteinsReceptor, ErbB-3cell invasioncell migrationErbB heterodimersErbB homodimersnon-apoptotic blebbingoesophageal cancer

Identifiers

PMID28940194
PMCPMC5693673
OpenAlexW2906314010

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.